# To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Tablets To Merrell Dow's 50 mg Norpramin Tablets

> **NCT00914004** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 36 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Desipramine HCl 50 mg Tablets Cord Laboratories
- **DRUG:** Norpramin 50 mg Tablets Merrell Dow Pharmaceuticals, Inc

## Key facts

- **NCT ID:** NCT00914004
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914004, "To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Tablets To Merrell Dow's 50 mg Norpramin Tablets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00914004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
